IMARC Group, a leading market research company, has recently releases report titled “Pyrogen Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” The study provides a detailed analysis of the industry, including the global pyrogen testing market trends, share, size, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the pyrogen testing market?

The global pyrogen testing market size reached US$ 1.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.2 Billion by 2028, exhibiting a growth rate (CAGR) of 10.3% during 2023-2028.

Request for a sample copy of this report: https://www.imarcgroup.com/pyrogen-testing-market/requestsample

What is pyrogen testing?

Pyrogen testing is conducted to detect endotoxin and non-endotoxin pyrogenic impurities in aqueous parenteral. It assists in avoiding life-threatening diseases, ensuring the safety of the medical device and parenteral pharmaceutical product, and fatal endotoxic shock induced by substances. Commonly utilized methods of pyrogen testing include the recombinant factor C (RFC) test, limulus amebocyte lysate (LAL) test, rabbit pyrogen test (RPT), and monocyte activation test (MAT). In addition, it is sensitive, robust, and scalable. As a result, pyrogen testing finds widespread applications in healthcare, biologics, and pharmaceuticals across the globe.

What are the growth prospects and trends in the pyrogen testing industry?

The escalating demand for these solutions to safely develop and release infection-free products at a cost-effective price and to determine the presence of metabolites or microbes in drugs during the production process is among the primary factors driving the pyrogen testing market. Besides this, the expanding pharmaceutical and biotechnology industries across the globe and the elevating presence of chronic ailments, such as cancer, heart disease, and diabetes, are further augmenting the market growth. Moreover, the growing popularity of pyrogen testing in the production of COVID-19 vaccines, as it aids in improving the management of infectious illnesses by determining the disease recovery, severity, and sequelae, is also catalyzing the global market. Apart from this, the leading players are introducing cost-effective and technologically advanced techniques that offer a more relevant projection of pyrogenic activity compared to the conventional methods, which is acting as another significant growth-inducing factor. Furthermore, the launch of several policies by the government bodies to fund research and development (RD) activities to create new therapeutics is anticipated to propel the pyrogen testing market over the forecasted period.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Product:

• Instruments
• Kits and Reagents
• Services

Breakup by Test Type:

• In-vitro Tests
• LAL Tests
• Rabbit Tests
• Others

Breakup by Application:

• Pharmaceutical and Biologics
• Medical Devices
• Others

Breakup by Region:

• North America (U.S. Canada)
• Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
• Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
• Latin America (Brazil, Mexico)
• Middle East Africa

Who are the key players operating in the industry?

The report covers the major market players including:

• Charles River Laboratories International Inc
• Ellab A/S
• Fujifilm Wako Pure Chemical Corporation (Fujifilm Holdings Corporation)
• Lonza Group AG
• Merck KGaA
• Microcoat Biotechnologie GmbH
• Nelson Laboratories LLC (Sotera Health)
• North American Science Associates Inc
• Pacific Biolabs Inc
• Sanquin
• Thermo Fisher Scientific Inc
• Toxikon Corporation
• Wuxi Apptec

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal